Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2023 for CombiGene, €8,493.
Filing timeline
BuySaleLars-Peter Ekolind
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lars-Peter Ekolind: trading record in brief
Our data holds just one disclosure by Lars-Peter Ekolind, dated 14 November 2023, reporting an open-market purchase worth €8,493 in CombiGene. Further filings will be added here. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lars-Peter Ekolind
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 37,366 shares@ SEK 2.64100.0% of flowAktieISIN SE0016101935FI:csv-b03adb59350626c18927Canonical exit: 12 Feb 2024 (T+90)
1 of 1 declaration